Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of minoxidil may cause hair follicles to transform into noticeable terminal hairs, leading to trichostasis spinulosa.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Aromatase inhibitors cause male pattern hair loss in women.

Finasteride improves hair loss in women with hyperandrogenism.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Topical minoxidil improves female pattern hair loss, finasteride not effective, laser devices show mixed results.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

Temporal hair loss relates to overall scalp hair loss in women.

Dermatologists need better training on Black hair to improve care and outcomes.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

Women with female pattern hair loss often underestimate how severe it is.

Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Treat pattern hair loss with finasteride and topical minoxidil.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.